IL18 and diabetes mellitus: This result was concordant with data from NOD mouse models that included IL-1 receptor- (138), Caspase-1- (139, 140), IL-1β- (140) and IL-18- (141)-deficient NOD mice, where no significant changes to diabetes protection were observed with any of these mutations.